Farther Finance Advisors’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Farther Finance Advisors’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-22	Closed	-$89	–	3780
2023 Q4	$89	Buy	+22	New	+$67	﹤0.01%	3317

Farther Finance Advisors's THRX Position: Q1 2024 in Review

Farther Finance Advisors sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 22 shares — an estimated $89 sold.

Farther Finance Advisors first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $89 in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Farther Finance Advisors reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Farther Finance Advisors sold 22 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $89.
Farther Finance Advisors first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Farther Finance Advisors's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $89 in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Farther Finance Advisors's 13F filing for Q1 2024, filed 14 May 2024.